Suicide Specific Rumination in Veterans
Reducing Suicide-Specific Rumination in Veterans Using Real-time Functional Magnetic Resonance Imaging Neurofeedback
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Philip R Szeszko, PhD
- Phone Number: 5869 (718) 584-9000
- Email: Philip.Szeszko@va.gov
Study Locations
-
-
New York
-
The Bronx, New York, United States, 10468-3904
- James J. Peters VA Medical Center, Bronx, NY
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- U.S. military Veteran
- negative pregnancy test on MRI scan days
- score greater than or equal to 10 on the Suicide Rumination Scale
- clinically stabilized on psychotropic medications
- engaged in mental health care treatment
- able to provide written, informed consent
Exclusion Criteria:
- no major medical or neurological disorders that could interfere with treatment
- moderate or severe traumatic brain injury
- current imminent suicide risk, as determined through psychiatric interview, responses to C-SSRS, and clinical judgment of the assessor
- any current psychotic disorder
- MRI contraindications
- any substance use disorder for substances other than cannabis or alcohol (mild alcohol or cannabis use disorder does not exclude participants but moderate or severe alcohol or cannabis substance use disorder is disqualifying)
- pregnant or trying to become pregnant
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Real-time fMRI Neurofeedback
This is a pilot study to collect feasibility and acceptability data regarding the utility of real-time functional magnetic resonance imaging feedback for Veterans experiencing suicide-specific rumination.
All study participants will receive the intervention.
|
The proposed pilot study is designed to collect feasibility and acceptability data regarding the utility of real-time functional magnetic resonance imaging (rt-fMRI) feedback in reducing suicide-specific rumination in Veterans.
Fifteen Veterans will receive 2 rt-fMRI neurofeedback sessions while attempting to alter connectivity in brain regions that play a role in rumination.
Pre- and post-treatment assessments of suicide, disability, functional impairment, and quality of life will be collected.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability and Feasibility
Time Frame: Total score obtained 2 weeks following first real-time fMRI neurofeedback session.
|
The Client Satisfaction Questionnaire will be used to assess acceptability and feasibility of implementing real-time fMRI neurofeedback in a Veteran population.
The total score on the questionnaire ranges from from 8 to 32 with higher scores indicative of greater satisfaction.
|
Total score obtained 2 weeks following first real-time fMRI neurofeedback session.
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Suicide Rumination Scale
Time Frame: Change in total score from pre-treatment to post-treatment (2 weeks).
|
The Suicide Rumination Scale is a self-report inventory designed to quantify the extent to which an individual ruminates about suicide.
The total score on the scale ranges from 0 to 32 with higher scores indicative of greater rumination.
|
Change in total score from pre-treatment to post-treatment (2 weeks).
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Philip R Szeszko, PhD, James J. Peters Veterans Affairs Medical Center
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- D5132-P
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.